161 related articles for article (PubMed ID: 3376373)
21. [The risk of tumor cell implantation by multiple selected bladder mucosal biopsies].
Jakse G; Hofstädter F
Urologe A; 1982 Jul; 21(4):182-4. PubMed ID: 6890255
[TBL] [Abstract][Full Text] [Related]
22. [Recurrent and up-grading bladder cancer in a young female: a case report].
Ouchi H; Noguchi S; Masuda M; Yao M; Kubota Y; Hosaka M
Hinyokika Kiyo; 1996 Apr; 42(4):311-3. PubMed ID: 8693967
[TBL] [Abstract][Full Text] [Related]
23. Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder.
Karam JA; Lotan Y; Ashfaq R; Sagalowsky AI; Shariat SF
Urology; 2007 Sep; 70(3):482-6. PubMed ID: 17905101
[TBL] [Abstract][Full Text] [Related]
24. Combined local bladder hyperthermia and intravesical chemotherapy for the treatment of high-grade superficial bladder cancer.
Gofrit ON; Shapiro A; Pode D; Sidi A; Nativ O; Leib Z; Witjes JA; van der Heijden AG; Naspro R; Colombo R
Urology; 2004 Mar; 63(3):466-71. PubMed ID: 15028439
[TBL] [Abstract][Full Text] [Related]
25. Recurrence, progression and success in stage Ta grade 3 bladder tumors treated with low dose bacillus Calmette-Guerin instillations.
Lebret T; Bohin D; Kassardjian Z; Herve JM; Molinie V; Barre P; Lugagne PM; Botto H
J Urol; 2000 Jan; 163(1):63-7. PubMed ID: 10604315
[TBL] [Abstract][Full Text] [Related]
26. The expression of p53 and bcl-2 in superficial bladder transitional cell carcinoma and its role in the outcome of postoperative intravesical chemotherapy.
Tzai TS; Chow NH; Lin JS; Yang WH; Tong YC
Anticancer Res; 1998; 18(6B):4717-21. PubMed ID: 9891547
[TBL] [Abstract][Full Text] [Related]
27. [The value of urine phosphohexose isomerase activity in comparison with urine cytology. First diagnosis and tumor after-care in patients with cancer of the urinary bladder].
Voigt W; Rothauge CF; Schäffer R
Urologe A; 1994 May; 33(3):235-42. PubMed ID: 8053092
[TBL] [Abstract][Full Text] [Related]
28. [Intestinal obstruction secondary to peritoneal carcinomatosis after iatrogenic perforation during TUR for transitional cell carcinoma of the bladder].
de la Cruz Ruiz M; Rivero Martínez MD; Fernández Domínguez L; Egea Camacho J; Cortiñas González JR; Rivera Ferro J; Fernández del Busto E
Arch Esp Urol; 1999 Dec; 52(10):1079-82. PubMed ID: 10680232
[TBL] [Abstract][Full Text] [Related]
29. TUR and adjuvant intravesical chemotherapy in T1G3 bladder tumors: recurrence, progression and survival in 137 selected patients followed up to 20 years.
Serretta V; Pavone C; Ingargiola GB; Daricello G; Allegro R; Pavone-Macaluso M
Eur Urol; 2004 Jun; 45(6):730-5; discussion 735-6. PubMed ID: 15149744
[TBL] [Abstract][Full Text] [Related]
30. [Prognostic significance of dysplastic urothelial changes for the rate of recurrence in superficial urinary bladder cancer].
Flamm J
Z Urol Nephrol; 1987 Nov; 80(11):641-6. PubMed ID: 3439374
[TBL] [Abstract][Full Text] [Related]
31. [Therapy and follow-up of superficial bladder cancer in in patients less than 30 years of age].
Erpenbach K; Roth S; Rathert P
Urologe A; 1994 Nov; 33(6):475-8. PubMed ID: 7817442
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors for primary superficial transitional cell carcinoma of the bladder: a retrospective cohort study.
Yang TB; Zeng FH; Sun ZQ
Chin Med J (Engl); 2006 Nov; 119(21):1821-8. PubMed ID: 17097038
[TBL] [Abstract][Full Text] [Related]
33. 5-aminolaevulinic acid-induced fluorescence cystoscopy during transurethral resection reduces the risk of recurrence in stage Ta/T1 bladder cancer.
Babjuk M; Soukup V; Petrík R; Jirsa M; Dvorácek J
BJU Int; 2005 Oct; 96(6):798-802. PubMed ID: 16153204
[TBL] [Abstract][Full Text] [Related]
34. Urinary fibronectin as a predictor of a residual tumour load after transurethral resection of bladder transitional cell carcinoma.
Li LY; Yang M; Zhang HB; Su XK; Xu WF; Chen Y; Shen ZJ; Gao X
BJU Int; 2008 Aug; 102(5):566-71. PubMed ID: 18410436
[TBL] [Abstract][Full Text] [Related]
35. [Clinical statistics of the bladder tumor--transurethral resection cases].
Uchida T; Ao T; Ikeda S; Yokoyama E; Kadowaki K; Shoji K; Koshiba K
Hinyokika Kiyo; 1990 Sep; 36(9):1033-8. PubMed ID: 2239608
[TBL] [Abstract][Full Text] [Related]
36. Surgically treated transitional cell carcinomas of the bladder. The role of radical surgery.
Al-Ali MA; Kashmoula DM; Haddad LF
Saudi Med J; 2002 Jun; 23(6):695-9. PubMed ID: 12070550
[TBL] [Abstract][Full Text] [Related]
37. [The presence of muscularis mucosae in the urinary bladder of samples from transurethral resection].
Sánchez-Chapado M; Angulo Cuesta J
Arch Esp Urol; 1995 Mar; 48(2):117-22. PubMed ID: 7755416
[TBL] [Abstract][Full Text] [Related]
38. Clinical panurothelial disease in patients with superficial bladder tumors: therapeutic implications.
Solsona E; Iborra I; Ricos JV; Monros JL; Rubio J; Almenar S
J Urol; 2002 May; 167(5):2007-11. PubMed ID: 11956428
[TBL] [Abstract][Full Text] [Related]
39. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin: a prospective, randomized clinical trial.
Divrik RT; Yildirim U; Zorlu F; Ozen H
J Urol; 2006 May; 175(5):1641-4. PubMed ID: 16600720
[TBL] [Abstract][Full Text] [Related]
40. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
